Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Effects of non-pharmaceutical interventions on COVID-19: A Tale of Three Models

Vincent Chin, John Ioannidis, Martin Tanner, Sally Cripps
doi: https://doi.org/10.1101/2020.07.22.20160341
Vincent Chin
1 The University of Sydney;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: vincent.chin@sydney.edu.au
John Ioannidis
2 Stanford University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jioannid@stanford.edu
Martin Tanner
3 Northwestern University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: martinatanner@gmail.com
Sally Cripps
1 The University of Sydney;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sally.cripps@sydney.edu.au
  • Abstract
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

In this paper, we compare the inference regarding the effectiveness of the various non-pharmaceutical interventions (NPIs) for COVID-19 obtained from three SIR models, all developed by the Imperial College COVID-19 Response Team. One model was applied to European countries and published in Nature (model 1), concluding that complete lockdown was by far the most effective measure, responsible for 80% of the reduction in R_t, and 3 million deaths were avoided in the examined countries. The Imperial College team applied a different model to the USA states (model 2), and in response to our original submission, the Imperial team has proposed in a referee report a third model which is a hybrid of the first two models (model 3). We demonstrate that inference is highly nonrobust to model specification. In particular, inference regarding the relative effectiveness of NPIs changes substantially with the model and decision makers who are unaware of, or ignore, model uncertainty are underestimating the risk attached to any decisions based on that model. Our primary observation is that by applying to European countries the model that the Imperial College team used for the USA states (model 2), complete lockdown has no or little effect, since it was introduced typically at a point when R_t was already very low. Moreover, using several state-of-the-art metrics for Bayesian model comparison, we demonstrate that model 2 (when applied to the European data) is better supported by the data than the model published in Nature. In particular, serious doubt is cast on the conclusions in Flaxman et al., whether we examine the data up to May 5th (as in Flaxman et al.) or beyond the point when NPIs began to be lifted. Only by objectively considering a wide variety of models in a statistically principled manner, can one begin to address the effectiveness of NPIs such as lockdown. The approach outlined in this paper provides one such path.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Not applicable.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All source code for the replication of our results is available from the Imperial College COVID-19 Response Team's Github repository. Daily confirmed cases and deaths data are publicly available from the European Centre of Disease Control's website.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 13, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Effects of non-pharmaceutical interventions on COVID-19: A Tale of Three Models
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Effects of non-pharmaceutical interventions on COVID-19: A Tale of Three Models
Vincent Chin, John Ioannidis, Martin Tanner, Sally Cripps
medRxiv 2020.07.22.20160341; doi: https://doi.org/10.1101/2020.07.22.20160341
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Effects of non-pharmaceutical interventions on COVID-19: A Tale of Three Models
Vincent Chin, John Ioannidis, Martin Tanner, Sally Cripps
medRxiv 2020.07.22.20160341; doi: https://doi.org/10.1101/2020.07.22.20160341

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Policy
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (144)
  • Anesthesia (47)
  • Cardiovascular Medicine (419)
  • Dentistry and Oral Medicine (74)
  • Dermatology (49)
  • Emergency Medicine (148)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (176)
  • Epidemiology (4908)
  • Forensic Medicine (3)
  • Gastroenterology (185)
  • Genetic and Genomic Medicine (690)
  • Geriatric Medicine (72)
  • Health Economics (193)
  • Health Informatics (636)
  • Health Policy (325)
  • Health Systems and Quality Improvement (209)
  • Hematology (87)
  • HIV/AIDS (157)
  • Infectious Diseases (except HIV/AIDS) (5414)
  • Intensive Care and Critical Care Medicine (334)
  • Medical Education (96)
  • Medical Ethics (24)
  • Nephrology (77)
  • Neurology (692)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (130)
  • Occupational and Environmental Health (211)
  • Oncology (447)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (91)
  • Pain Medicine (37)
  • Palliative Medicine (18)
  • Pathology (131)
  • Pediatrics (203)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (88)
  • Psychiatry and Clinical Psychology (788)
  • Public and Global Health (1833)
  • Radiology and Imaging (328)
  • Rehabilitation Medicine and Physical Therapy (142)
  • Respiratory Medicine (258)
  • Rheumatology (88)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (63)
  • Surgery (102)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (39)